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Abstract
Background:  Consumers of research (researchers, administrators, educators and clinicians)
frequently use standard critical appraisal tools to evaluate the quality of published research reports.
However, there is no consensus regarding the most appropriate critical appraisal tool for allied
health research. We summarized the content, intent, construction and psychometric properties of
published, currently available critical appraisal tools to identify common elements and their
relevance to allied health research.
Methods: A systematic review was undertaken of 121 published critical appraisal tools sourced
from 108 papers located on electronic databases and the Internet. The tools were classified
according to the study design for which they were intended. Their items were then classified into
one of 12 criteria based on their intent. Commonly occurring items were identified. The empirical
basis for construction of the tool, the method by which overall quality of the study was established,
the psychometric properties of the critical appraisal tools and whether guidelines were provided
for their use were also recorded.
Results: Eighty-seven percent of critical appraisal tools were specific to a research design, with
most tools having been developed for experimental studies. There was considerable variability in
items contained in the critical appraisal tools. Twelve percent of available tools were developed
using specified empirical research. Forty-nine percent of the critical appraisal tools summarized the
quality appraisal into a numeric summary score. Few critical appraisal tools had documented
evidence of validity of their items, or reliability of use. Guidelines regarding administration of the
tools were provided in 43% of cases.
Conclusions:  There was considerable variability in intent, components, construction and
psychometric properties of published critical appraisal tools for research reports. There is no "gold
standard' critical appraisal tool for any study design, nor is there any widely accepted generic tool
that can be applied equally well across study types. No tool was specific to allied health research
requirements. Thus interpretation of critical appraisal of research reports currently needs to be
considered in light of the properties and intent of the critical appraisal tool chosen for the task.
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Background
Consumers of research (clinicians, researchers, educators,
administrators) frequently use standard critical appraisal
tools to evaluate the quality and utility of published
research reports [1]. Critical appraisal tools provide ana-
lytical evaluations of the quality of the study, in particular
the methods applied to minimise biases in a research
project [2]. As these factors potentially influence study
results, and the way that the study findings are inter-
preted, this information is vital for consumers of research
to ascertain whether the results of the study can be
believed, and transferred appropriately into other envi-
ronments, such as policy, further research studies, educa-
tion or clinical practice. Hence, choosing an appropriate
critical appraisal tool is an important component of evi-
dence-based practice.
Although the importance of critical appraisal tools has
been acknowledged [1,3-5] there appears to be no consen-
sus regarding the 'gold standard' tool for any medical evi-
dence. In addition, it seems that consumers of research are
faced with a large number of critical appraisal tools from
which to choose. This is evidenced by the recent report by
the Agency for Health Research Quality in which 93 criti-
cal appraisal tools for quantitative studies were identified
[6]. Such choice may pose problems for research consum-
ers, as dissimilar findings may well be the result when dif-
ferent critical appraisal tools are used to evaluate the same
research report [6].
Critical appraisal tools can be broadly classified into those
that are research design-specific and those that are generic.
Design-specific tools contain items that address method-
ological issues that are unique to the research design [5,7].
This precludes comparison however of the quality of dif-
ferent study designs [8]. To attempt to overcome this lim-
itation, generic critical appraisal tools have been
developed, in an attempt to enhance the ability of
research consumers to synthesise evidence from a range of
quantitative and or qualitative study designs (for instance
[9]). There is no evidence that generic critical appraisal
tools and design-specific tools provide a comparative
evaluation of research designs.
Moreover, there appears to be little consensus regarding
the most appropriate items that should be contained
within any critical appraisal tool. This paper is concerned
primarily with critical appraisal tools that address the
unique properties of allied health care and research [10].
This approach was taken because of the unique nature of
allied health contacts with patients, and because evidence-
based practice is an emerging area in allied health [10].
The availability of so many critical appraisal tools (for
instance [6]) may well prove daunting for allied health
practitioners who are learning to critically appraise
research in their area of interest. For the purposes of this
evaluation, allied health is defined as encompassing "...all
occasions of service to non admitted patients where serv-
ices are provided at units/clinics providing treatment/
counseling to patients. These include units primarily con-
cerned with physiotherapy, speech therapy, family pan-
ning, dietary advice, optometry occupational therapy..."
[11].
The unique nature of allied health practice needs to be
considered in allied health research. Allied health research
thus differs from most medical research, with respect to:
• the paradigm underpinning comprehensive and clini-
cally-reasoned descriptions of diagnosis (including valid-
ity and reliability). An example of this is in research into
low back pain, where instead of diagnosis being made on
location and chronicity of pain (as is common) [12], it
would be made on the spinal structure and the nature of
the dysfunction underpinning the symptoms, which is
arrived at by a staged and replicable clinical reasoning
process [10,13].
• the frequent use of multiple interventions within the
one contact with the patient (an occasion of service), each
of which requires appropriate description in terms of rela-
tionship to the diagnosis, nature, intensity, frequency,
type of instruction provided to the patient, and the order
in which the interventions were applied [13]
• the timeframe and frequency of contact with the patient
(as many allied health disciplines treat patients in epi-
sodes of care that contain multiple occasions of service,
and which can span many weeks, or even years in the case
of chronic problems [14])
• measures of outcome, including appropriate methods
and timeframes of measuring change in impairment,
function, disability and handicap that address the needs
of different stakeholders (patients, therapists, funders etc)
[10,12,13].
Methods
Search strategy
In supplementary data [see additional file 1].
Data organization and extraction
Two independent researchers (PK, NMW) participated in
all aspects of this review, and they compared and dis-
cussed their findings with respect to inclusion of critical
appraisal tools, their intent, components, data extraction
and item classification, construction and psychometric
properties. Disagreements were resolved by discussion
with a third member of the team (KG).BMC Medical Research Methodology 2004, 4:22 http://www.biomedcentral.com/1471-2288/4/22
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Data extraction consisted of a four-staged process. First,
identical replica critical appraisal tools were identified
and removed prior to analysis. The remaining critical
appraisal tools were then classified according to the study
design for which they were intended to be used [1,2]. The
scientific manner in which the tools had been constructed
was classified as whether an empirical research approach
has been used, and if so, which type of research had been
undertaken. Finally, the items contained in each critical
appraisal tool were extracted and classified into one of
eleven groups, which were based on the criteria described
by Clarke and Oxman [4] as:
• Study aims and justification
• Methodology used, which encompassed method of
identification of relevant studies and adherence to study
protocol;
• Sample selection, which ranged from inclusion and
exclusion criteria, to homogeneity of groups;
• Method of randomization and allocation blinding;
• Attrition: response and drop out rates;
• Blinding of the clinician, assessor, patient and statisti-
cian as well as the method of blinding;
• Outcome measure characteristics;
• Intervention or exposure details;
• Method of data analyses;
• Potential sources of bias; and
• Issues of external validity, which ranged from applica-
tion of evidence to other settings to the relationship
between benefits, cost and harm.
An additional group, "miscellaneous", was used to
describe items that could not be classified into any of the
groups listed above.
Data synthesis
Data was synthesized using MS Excel spread sheets as well
as narrative format by describing the number of critical
appraisal tools per study design and the type of items they
contained. Descriptions were made of the method by
which the overall quality of the study was determined, evi-
dence regarding the psychometric properties of the tools
(validity and reliability) and whether guidelines were pro-
vided for use of the critical appraisal tool.
Results
One hundred and ninety-three research reports that
potentially provided a description of a critical appraisal
tool (or process) were identified from the search strategy.
Fifty-six of these papers were unavailable for review due to
outdated Internet links, or inability to source the relevant
journal through Australian university and Government
library databases. Of the 127 papers retrieved, 19 were
excluded from this review, as they did not provide a
description of the critical appraisal tool used, or were pub-
lished in languages other than English. As a result, 108
papers were reviewed, which yielded 121 different critical
appraisal tools [1-5,7,9,15-102,116].
Empirical basis for tool construction
We identified 14 instruments (12% all tools) which were
reported as having been constructed using a specified
empirical approach [20,29,30,32,35,40,49,51,70-
72,79,103,116]. The empirical research reflected descrip-
tive and/or qualitative approaches, these being critical
review of existing tools [40,72], Delphi techniques to
identify then refine data items [32,51,71], questionnaires
and other forms of written surveys to identify and refine
data items [70,79,103], facilitated structured consensus
meetings [20,29,30,35,40,49,70,72,79,116], and pilot
validation testing [20,40,72,103,116]. In all the studies
which reported developing critical appraisal tools using a
consensus approach, a range of stakeholder input was
sought, reflecting researchers and clinicians in a range of
health disciplines, students, educators and consumers.
There were a further 31 papers which cited other studies as
the source of the tool used in the review, but which pro-
vided no information on why individual items had been
chosen, or whether (or how) they had been modified.
Moreover, for 21 of these tools, the cited sources of the
critical appraisal tool did not report the empirical basis on
which the tool had been constructed.
Number of critical appraisal tools per study design [1,2] Figure 1
Number of critical appraisal tools per study design [1,2]BMC Medical Research Methodology 2004, 4:22 http://www.biomedcentral.com/1471-2288/4/22
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Critical appraisal tools per study design
Seventy-eight percent (N = 94) of the critical appraisal
tools were developed for use on primary research [1-
5,7,9,18,19,25-27,34,37-41], while the remainder (N =
26) were for secondary research (systematic reviews and
meta-analyses) [2-5,15-36,116]. Eighty-seven percent (N
= 104) of all critical appraisal tools were design-specific
[2-5,7,9,15-90], with over one third (N = 45) developed
for experimental studies (randomized controlled trials,
clinical trials) [2-4,25-27,34,37-73]. Sixteen critical
appraisal tools were generic. Of these, six were developed
for use on both experimental and observational studies
[9,91-95], whereas 11 were purported to be useful for any
qualitative and quantitative research design [1,18,41,96-
102,116] (see Figure 1, Table 1).
Critical appraisal items
One thousand, four hundred and seventy five items were
extracted from these critical appraisal tools. After group-
ing like items together, 173 different item types were iden-
tified, with the most frequently reported items being
focused towards assessing the external validity of the
study (N = 35) and method of data analyses (N = 28)
(Table 2). The most frequently reported items across all
critical appraisal tools were:
• Eligibility criteria (inclusion/exclusion criteria) (N = 63)
• Appropriate statistical analyses (N = 47)
• Random allocation of subjects (N = 43)
• Consideration of outcome measures used (N = 43)
• Sample size justification/power calculations (N = 39)
• Study design reported (N = 36)
• Assessor blinding (N = 36)
Design-specific critical appraisal tools
Systematic reviews
Eighty-seven different items were extracted from the 26
critical appraisal tools, which were designed to evaluate
the quality of systematic reviews. These critical appraisal
tools frequently contained items regarding data analyses
and issues of external validity (Tables 2 and 3).
Items assessing data analyses were focused to the methods
used to summarize the results, assessment of sensitivity of
results and whether heterogeneity was considered,
whereas the nature of reporting of the main results, inter-
pretation of them and their generalizability were fre-
quently used to assess the external validity of the study
findings. Moreover, systematic review critical appraisal
tools tended to contain items such as identification of
relevant studies, search strategy used, number of studies
included and protocol adherence, that would not be rele-
vant for other study designs. Blinding and randomisation
procedures were rarely included in these critical appraisal
tools.
Experimental studies
One hundred and twenty thirteen different items were
extracted from the 45 experimental critical appraisal tools.
These items most frequently assessed aspects of data anal-
yses and blinding (Tables 1 and 2). Data analyses items
were focused on whether appropriate statistical analysis
Table 1: Summary of tools sourced in this review.
Research design focus of critical appraisal tools Critical appraisal tools with summary scores
Secondary studies Systematic reviews/meta-analyses 
[2-5,15-36,116]
All study designs [1,18,41,96-
102,116]
Summary score [18,41,96,97,116]
Primary studies Experimental studies [2-4,19,25-
27,34,37-73]
No summary score [1,98-102]
Diagnostic studies [19,74-79] Experimental studies Summary score [19,37-59]
Observational studies 
[2,3,7,19,25,66,72,80-86]
No summary score [2-
4,25,27,28,34,60-73]
Qualitative studies [9,26,66,87-90] Diagnostic studies Summary score [16,74-77]
Experimental & Observational 
studies [9,91-102]
No summary score [78,79]
Qualitative studies Summary score [87]
No summary score [9,26,66,88-
90]
Experimental and 
observational studies
Summary score [91-93]
No summary score [9,94,95]BMC Medical Research Methodology 2004, 4:22 http://www.biomedcentral.com/1471-2288/4/22
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Table 2: The type and number of component items contained in critical appraisal tools per study design.
Type of 
items
Design-specific critical appraisal tool components Generic critical appraisal 
tool components
Total
Systematic 
reviews
Experiment
al studies
Diagnostic 
studies
Observatio
nal studies
Qualitative 
studies
Exp & Obsa 
studies
All study 
designs
Study aims 
and 
justification
35 27 5 18 17 4 11 117
Methodology 
used
3 8 100001 4 0
Sample 
selection
30 62 12 37 10 10 14 175
Randomizatio
n
2 6 5 15065 8 4
Attrition 4 59 3 23 0 8 8 105
B l i n d i n g1 7 7 58057 1 0 3
Outcome 
measure 
characteristic
s
4 1 4 633 32 91 9 1 5 3
Intervention 7 42 3 13 0 5 12 82
Data analyses 83 91 14 54 12 14 27 295
B i a s 2 4 1 4 25036 5 4
External 
validity
72 50 12 30 27 9 27 227
M i s c e l l a n e o u s 1 1 1 2 75726 5 0
Total 348 546 67 331 75 75 143 1485
Table 3: The type and number of guidelines accompanying critical appraisal tools per study design
Type of critical 
appraisal tool
Type of guideline Total number of 
critical appraisal 
tools
Handbook/published paper Accompanying explanation Total
Number of tools References Number of tools References
Systematic reviews 9 [2,4,15,20,25,28,29
,331,36,116]
3 [16,26,27] 12 26
Experimental 
studies
10 [2,4,25,37,41,50,64
-66,69]
6 [26,40,49,51,57,59
]
16 45
Diagnostic studies 3 [74,75,76] 1 [79] 4 7
Observational 
studies
9 [2,25,66,80,84-87] 1 [83] 10 19
Qualitative studies 4 [9,87,89,90] 1 [26] 5 7
Experimental & 
Observational 
studies
2[ 9 , 9 5 ] 1[ 9 1 ] 3 6
All study designs 1 [100] 1 [102] 2 10
Total 38 14 52 120BMC Medical Research Methodology 2004, 4:22 http://www.biomedcentral.com/1471-2288/4/22
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was performed, whether a sample size justification or
power calculation was provided and whether side effects
of the intervention were recorded and analysed. Blinding
was focused on whether the participant, clinician and
assessor were blinded to the intervention.
Diagnostic studies
Forty-seven different items were extracted from the seven
diagnostic critical appraisal tools. These items frequently
addressed issues involving data analyses, external validity
of results and sample selection that were specific to diag-
nostic studies (whether the diagnostic criteria were
defined, definition of the "gold" standard, the calculation
of sensitivity and specificity) (Tables 1 and 2).
Observational studies
Seventy-four different items were extracted from the 19
critical appraisal tools for observational studies. These
items primarily focused on aspects of data analyses (see
Tables 1 and 2, such as whether confounders were consid-
ered in the analysis, whether a sample size justification or
power calculation was provided and whether appropriate
statistical analyses were preformed.
Qualitative studies
Thirty-six different items were extracted from the seven
qualitative study critical appraisal tools. The majority of
these items assessed issues regarding external validity,
methods of data analyses and the aims and justification of
the study (Tables 1 and 2). Specifically, items were
focused to whether the study question was clearly stated,
whether data analyses were clearly described and appro-
priate, and application of the study findings to the clinical
setting. Qualitative critical appraisal tools did not contain
items regarding sample selection, randomization, blind-
ing, intervention or bias, perhaps because these issues are
not relevant to the qualitative paradigm.
Generic critical appraisal tools
Experimental and observational studies
Forty-two different items were extracted from the six criti-
cal appraisal tools that could be used to evaluate experi-
mental and observational studies. These tools most
frequently contained items that addressed aspects of sam-
ple selection (such as inclusion/exclusion criteria of par-
ticipants, homogeneity of participants at baseline) and
data analyses (such as whether appropriate statistical
analyses were performed, whether a justification of the
sample size or power calculation were provided).
All study designs
Seventy-eight different items were contained in the ten
critical appraisal tools that could be used for all study
designs (quantitative and qualitative). The majority of
these items focused on whether appropriate data analyses
were undertaken (such as whether confounders were con-
sidered in the analysis, whether a sample size justification
or power calculation was provided and whether appropri-
ate statistical analyses were preformed) and external valid-
ity issues (generalization of results to the population,
value of the research findings) (see Tables 1 and 2).
Allied health critical appraisal tools
We found no critical appraisal instrument specific to
allied health research, despite finding at least seven critical
appraisal instruments associated with allied health topics
(mostly physiotherapy management of orthopedic condi-
tions) [37,39,52,58,59,65]. One critical appraisal devel-
opment group proposed two instruments [9], specific to
quantitative and qualitative research respectively. The
core elements of allied health research quality (specific
diagnosis criteria, intervention descriptions, nature of
patient contact and appropriate outcome measures) were
not addressed in any one tool sourced for this evaluation.
We identified 152 different ways of considering quality
reporting of outcome measures in the 121 critical
appraisal tools, and 81 ways of considering description of
interventions. Very few tools which were not specifically
targeted to diagnostic studies (less than 10% of the
remaining tools) addressed diagnostic criteria. The critical
appraisal instrument that seemed most related to allied
health research quality [39] sought comprehensive evalu-
ation of elements of intervention and outcome, however
this instrument was relevant only to physiotherapeutic
orthopedic experimental research.
Overall study quality
Forty-nine percent (N = 58) of critical appraisal tools sum-
marised the results of the quality appraisal into a single
numeric summary score [5,7,15-25,37-59,74-77,80-
83,87,91-93,96,97] (Figure 2). This was achieved by one
of two methods:
• An equal weighting system, where one point was allo-
cated to each item fulfilled; or
• A weighted system, where fulfilled items were allocated
various points depending on their perceived importance.
However, there was no justification provided for any of
the scoring systems used. In the remaining critical
appraisal tools (N = 62), a single numerical summary
score was not provided [1-4,9,25-36,60-73,78,79,84-
90,94,95,98-102]. This left the research consumer to sum-
marize the results of the appraisal in a narrative manner,
without the assistance of a standard approach.
Psychometric properties of critical appraisal tools
Few critical appraisal tools had documented evidence of
their validity and reliability. Face validity was establishedBMC Medical Research Methodology 2004, 4:22 http://www.biomedcentral.com/1471-2288/4/22
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in nine critical appraisal tools, seven of which were devel-
oped for use on experimental studies
[38,40,45,49,51,63,70] and two for systematic reviews
[32,103]. Intra-rater reliability was established for only
one critical appraisal tool as part of its empirical develop-
ment process [40], whereas inter-rater reliability was
reported for two systematic review tools [20,36] (for one
of these as part of the developmental process [20]) and
seven experimental critical appraisal tools
[38,40,45,51,55,56,63] (for two of these as part of the
developmental process [40,51]).
Critical appraisal tool guidelines
Forty-three percent (N = 52) of critical appraisal tools had
guidelines that informed the user of the interpretation of
each item contained within them (Table 2). These guide-
lines were most frequently in the form of a handbook or
published paper (N = 31)
[2,4,9,15,20,25,28,29,31,36,37,41,50,64-67,69,80,84-
87,89,90,95,100,116], whereas in 14 critical appraisal
tools explanations accompanied each item
[16,26,27,40,49,51,57,59,79,83,91,102].
Discussion
Our search strategy identified a large number of published
critical appraisal tools that are currently available to criti-
cally appraise research reports. There was a distinct lack of
information on tool development processes in most cases.
Many of the tools were reported to be modifications of
other published tools, or reflected specialty concerns in
specific clinical or research areas, without attempts to jus-
tify inclusion criteria. Less than 10 of these tools were rel-
evant to evaluation of the quality of allied health research,
and none of these were based on an empirical research
approach. We are concerned that although our search was
systematic and extensive [104,105], our broad key words
and our lack of ready access to 29% of potentially useful
papers (N = 56) potentially constrained us from identify-
ing all published critical appraisal tools. However, con-
sumers of research seeking critical appraisal instruments
are not likely to seek instruments from outdated Internet
links and unobtainable journals, thus we believe that we
identified the most readily available instruments. Thus,
despite the limitations on sourcing all possible tools, we
believe that this paper presents a useful synthesis of the
readily available critical appraisal tools.
The majority of the critical appraisal tools were developed
for a specific research design (87%), with most designed
for use on experimental studies (38% of all critical
appraisal tools sourced). This finding is not surprising as,
according to the medical model, experimental studies sit
at or near the top of the hierarchy of evidence [2,8]. In
recent years, allied health researchers have strived to apply
the medical model of research to their own discipline by
conducting experimental research, often by using the ran-
domized controlled trial design [106]. This trend may be
the reason for the development of experimental critical
appraisal tools reported in allied health-specific research
topics [37,39,52,58,59,65].
We also found a considerable number of critical appraisal
tools for systematic reviews (N = 26), which reflects the
trend to synthesize research evidence to make it relevant
for clinicians [105,107]. Systematic review critical
appraisal tools contained unique items (such as identifi-
cation of relevant studies, search strategy used, number of
studies included, protocol adherence) compared with
tools used for primary studies, a reflection of the second-
ary nature of data synthesis and analysis.
Number of critical appraisal tools with, and without, summary quality scores Figure 2
Number of critical appraisal tools with, and without, summary quality scoresBMC Medical Research Methodology 2004, 4:22 http://www.biomedcentral.com/1471-2288/4/22
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In contrast, we identified very few qualitative study critical
appraisal tools, despite the presence of many journal-spe-
cific guidelines that outline important methodological
aspects required in a manuscript submitted for publica-
tion [108-110]. This finding may reflect the more tradi-
tional, quantitative focus of allied health research [111].
Alternatively, qualitative researchers may view the
robustness of their research findings in different terms
compared with quantitative researchers [112,113]. Hence
the use of critical appraisal tools may be less appropriate
for the qualitative paradigm. This requires further
consideration.
Of the small number of generic critical appraisal tools, we
found few that could be usefully applied (to any health
research, and specifically to the allied health literature),
because of the generalist nature of their items, variable
interpretation (and applicability) of items across research
designs, and/or lack of summary scores. Whilst these types
of tools potentially facilitate the synthesis of evidence
across allied health research designs for clinicians, their
lack of specificity in asking the 'hard' questions about
research quality related to research design also potentially
precludes their adoption for allied health evidence-based
practice. At present, the gold standard study design when
synthesizing evidence is the randomized controlled trial
[4], which underpins our finding that experimental criti-
cal appraisal tools predominated in the allied health liter-
ature [37,39,52,58,59,65]. However, as more systematic
literature reviews are undertaken on allied health topics, it
may become more accepted that evidence in the form of
other research design types requires acknowledgement,
evaluation and synthesis. This may result in the develop-
ment of more appropriate and clinically useful allied
health critical appraisal tools.
A major finding of our study was the volume and varia-
tion in available critical appraisal tools. We found no gold
standard critical appraisal tool for any type of study
design. Therefore, consumers of research are faced with
frustrating decisions when attempting to select the most
appropriate tool for their needs. Variable quality evalua-
tions may be produced when different critical appraisal
tools are used on the same literature [6]. Thus, interpreta-
tion of critical analysis must be carefully considered in
light of the critical appraisal tool used.
The variability in the content of critical appraisal tools
could be accounted for by the lack of any empirical basis
of tool construction, established validity of item construc-
tion, and the lack of a gold standard against which to
compare new critical tools. As such, consumers of research
cannot be certain that the content of published critical
appraisal tools reflect the most important aspects of the
quality of studies that they assess [114]. Moreover, there
was little evidence of intra- or inter-rater reliability of the
critical appraisal tools. Coupled with the lack of protocols
for use, this may mean that critical appraisers could inter-
pret instrument items in different ways over repeated
occasions of use. This may produce variable results [123].
Conclusions
Based on the findings of this evaluation, we recommend
that consumers of research should carefully select critical
appraisal tools for their needs. The selected tools should
have published evidence of the empirical basis for their
construction, validity of items and reliability of interpre-
tation, as well as guidelines for use, so that the tools can
be applied and interpreted in a standardized manner. Our
findings highlight the need for consensus to be reached
regarding the important and core items for critical
appraisal tools that will produce a more standardized
environment for critical appraisal of research evidence. As
a consequence, allied health research will specifically ben-
efit from having critical appraisal tools that reflect best
practice research approaches which embed specific
research requirements of allied health disciplines.
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